Bencardino, S.; D’Amico, F.; Faggiani, I.; Bernardi, F.; Allocca, M.; Furfaro, F.; Parigi, T.L.; Zilli, A.; Fiorino, G.; Peyrin-Biroulet, L.;
et al. Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. J. Clin. Med. 2023, 12, 5014.
https://doi.org/10.3390/jcm12155014
AMA Style
Bencardino S, D’Amico F, Faggiani I, Bernardi F, Allocca M, Furfaro F, Parigi TL, Zilli A, Fiorino G, Peyrin-Biroulet L,
et al. Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. Journal of Clinical Medicine. 2023; 12(15):5014.
https://doi.org/10.3390/jcm12155014
Chicago/Turabian Style
Bencardino, Sarah, Ferdinando D’Amico, Ilaria Faggiani, Francesca Bernardi, Mariangela Allocca, Federica Furfaro, Tommaso Lorenzo Parigi, Alessandra Zilli, Gionata Fiorino, Laurent Peyrin-Biroulet,
and et al. 2023. "Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis" Journal of Clinical Medicine 12, no. 15: 5014.
https://doi.org/10.3390/jcm12155014
APA Style
Bencardino, S., D’Amico, F., Faggiani, I., Bernardi, F., Allocca, M., Furfaro, F., Parigi, T. L., Zilli, A., Fiorino, G., Peyrin-Biroulet, L., & Danese, S.
(2023). Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. Journal of Clinical Medicine, 12(15), 5014.
https://doi.org/10.3390/jcm12155014